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Abstract
Background: Regulated protein-protein interactions (PPIs) are pivotal molecular switches that
are important for the regulation of signaling processes within eukaryotic cells. Cellular signaling is
altered in various disease conditions and offers interesting options for pharmacological
interventions. Constitutive PPIs are usually mediated by large interaction domains. In contrast,
stimulus-regulated PPIs often depend on small post-translational modifications and are thus better
suited targets for drug development. However, the detection of modification-dependent PPIs with
biochemical methods still remains a labour- and material-intensive task, and many pivotal PPIs that
are potentially suited for pharmacological intervention most likely remain to be identified. The
availability of methods to easily identify and quantify stimulus-dependent, potentially also transient
interaction events, is therefore essential. The assays should be applicable to intact mammalian cells,
optimally also to primary cells in culture.
Results: In this study, we adapted the split-TEV system to quantify phosphorylation-dependent and
transient PPIs that occur at the membrane and in the cytosol of living mammalian cells. Split-TEV
is based on a PPI-induced functional complementation of two inactive TEV protease fragments
fused to interaction partners of choice. Genetically encoded transcription-coupled and proteolysis-
only TEV reporter systems were used to convert the TEV activity into an easily quantifiable
readout. We measured the phosphorylation-dependent interaction between the pro-apoptotic
protein Bad and the adapter proteins 14-3-3ε and ζ in NIH-3T3 fibroblasts and in primary cultured
neurons. Using split-TEV assays, we show that Bad specifically interacts with 14-3-3 isoforms when
phosphorylated by protein kinase Akt-1/PKB at Ser136. We also measured the phosphorylation-
dependent Bad/14-3-3 interactions mediated by endogenous and transient Akt-1 activity. We
furthermore applied split-TEV assays to measure the phosphorylation-dependent interactions of
Neuregulin-1-stimulated ErbB4 receptors with several adapter proteins.
Conclusion:  Split-TEV assays are well suited to measure phosphorylation-dependent and
transient PPIs that occur specifically at the membrane and in the cytosol of heterologous and
primary cultured mammalian cells. Given the high sensitivity of the split-TEV system, all assays were
performed in multi-plate formats and could be adapted for higher throughput to screen for
pharmacologically active substances.
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Background
Constitutive and regulated PPIs are the main organizing
principles within signaling cascades the integration of
which results in an adaptive cellular behaviour. Modifica-
tion-dependent PPIs are often positioned at pivotal posi-
tions within signaling pathways, and are thus central to
signaling processes at the membrane and in the cytosol of
living mammalian cells [1]. Phosphorylation of specific
serine or threonine residues by kinases represents the pro-
totype and most abundant type of post-translational pro-
tein modifications [2]. In light of the fact that cellular
signaling is altered in many disease conditions, functional
subunits of signaling processes are the focus of intense
research, since they represent attractive targets for phar-
macological intervention [3]. In contrast to constitutive
PPIs, stimulus-regulated PPIs often depend on small post-
translational modifications, and are thus better suited tar-
gets for drug development [4]. However, the detection of
modification-dependent PPIs with biochemical methods
still remains a labour- and material-intensive task, and
many pivotal PPIs potentially suited for pharmacological
perturbation most likely still remain to be identified.
Therefore, the availability of methods to easily screen and
identify stimulus-dependent, potentially transient, inter-
action events is essential. Ideally, the assays should be
applicable to intact mammalian cells, including cultured
primary cells.
Recently, we reported the development of the split-TEV
approach that allowed us to monitor the ligand-induced
dimerisation of ErbB receptors at the membrane of mam-
malian cells [5]. Split-TEV is based on the functional com-
plementation of two inactive TEV protease fragments
fused to interacting proteins. The PPI-dependent TEV pro-
tease activity can be followed by several reporters, which
either rely on a fluorescent or a luminescent readout [5].
In this study, we wanted to adapt the split-TEV system to
analyse constitutive and phosphorylation-dependent
interactions of full-length proteins that occur in the
cytosol and at the membrane. For the technical proof-of-
principle for cytosolic interactions, we chose the interac-
tions between Bad and 14-3-3 isoforms as a model system
[6,7]. Both, the 14-3-3 and Bad proteins are involved in
the regulation of apoptosis and survival signaling [8,9].
Bad is a pro-apoptotic protein exerting its action by bind-
ing to the anti-apoptotic, mitochondrially localised pro-
teins Bcl-XL and Bcl2, thereby inactivating the Bcl proteins
[10]. However, upon phosphorylation at serine 136 by
protein kinase Akt-1/PKB, Bad can be complexed by 14-3-
3 proteins in the cytosol, thus preventing the association
with the Bcl proteins and inhibiting apoptosis [6,11]. 14-
3-3 proteins were shown to be involved in sequestering
functions through binding to phoshorylated proteins and
consequently influencing signaling events [9,11]. There
are seven 14-3-3 genes giving rise to the seven isoforms β,
γ, ε, η, σ, τ (or θ) and ζ. The 14-3-3 isoforms can function-
ally compensate for each other, but can also mediate spe-
cific cellular functions: the σ isoform for example is
implicated in cancer and cell cycle regulation [9,12],
whereas the isoforms ε and ζ are highly expressed in post-
mitotic cells of the brain [13]. Additionally, 14-3-3 pro-
teins can homo- and heterodimerise [9].
To demonstrate the applicability of the split-TEV system
to analyse phosphorylation-dependent interactions at the
membrane, we chose stimulus-dependent interactions of
the ErbB4 receptor with various cytosolic adapter pro-
teins. ErbB4 belongs to the family of ErbB receptor tyro-
sine kinases, which are involved in diverse signaling
mechanisms ranging from proliferation to differentiation
and neuronal specification [14-16]. Upon ligand binding,
ErbB4 homo- or heterodimerises, followed by an auto-
phosphorylation in trans, which then leads to the recruit-
ment of SH2 domain-containing adaptor proteins, such as
Grb2, Shc1 and the regulatory subunit of PI3K (PI3Kp85)
[20,21]. Neuregulin-1 (Nrg1) represents the best charac-
terized ErbB4 ligand and has been shown to be implicated
several diseases, including cancer and schizophrenia [17-
19].
In this report, we measured the homo- and heterodimeric
interactions of 14-3-3 isoforms and the modification-
dependent interaction between full-length cytosolic Bad
and 14-3-3 isoforms ε and ζ in heterologous NIH-3T3
cells and primary neurons using the split-TEV system.
Moreover, we measured the Nrg1-induced interactions of
several SH2-adapter proteins with phosphorylated ErbB4
in living cells.
Results
Split-TEV reporters to monitor interactions of cytoplasmic 
proteins
Protein-protein interactions can be measured using a pro-
tein complementation approach that is based on TEV pro-
tease and is termed split-TEV [5]. In this system, inactive
TEV protease fragments are fused to potentially interacting
proteins. Upon interaction the reconstituted functional
protease activates genetically encoded TEV-specific report-
ers [5]. The cytosolic reporters used are either proteolysis-
only reporters requiring only one step of activation
(LucER, RedERnuc) or transcription-coupled reporters
with a two-step activation, which consist of the proteolytic
activation of the previously silent transcriptional activator
GV and the transcriptional activation of a final reporter
gene (firefly luciferase or EGFP) (Fig. 1a). The functional-
ity of all cytosolic reporters relies on the modified ligand
binding domain of the estrogen receptor, termed ERT2
[22]. For LucER, this domain substantially decreases the
biological activity of the luciferase unit, and for GV-2ER,
GV is trapped in the cytosol, unless both ERT2 domainsBMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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Analysis of cytosolic split-TEV reporters to monitor the dimerization of 14-3-3 proteins Figure 1
Analysis of cytosolic split-TEV reporters to monitor the dimerization of 14-3-3 proteins. (a) The flow-chart 
depicts the transcription-coupled reporter systems (GV-ER/GV-2ER used in combination with a GV-dependent reporter con-
struct) and the proteolysis-only reporter systems (RedERnuc/LucER). Whereas the readout via the transcription-coupled 
reporter systems is generated by two steps, namely proteolytic cleavage and transcriptional activation, the proteolysis-only 
reporter systems require the proteolytic activation only. Transcription-coupled reporters are inactivated transcription factors; 
proteolysis-only reporters are inactivated final reporter proteins. tevS, TEV protease cleavage site; GV, artificial transcription 
factor composed of the DNA-binding domain of Gal4 from yeast and the transactivation domain VP16 from herpes simplex 
virus; DsRednuc, nuclear variant of DsRed; Luciferase, firefly luciferase moiety; ERT2, modified ligand binding domain of the 
estrogen receptor. (b, c) Luciferase (a) and FACS (b) assays showing the dimerization of the 14-3-3ε isoform with all cytosolic 
reporters. NIH-3T3 cells were transfected with the indicated combinations of constructs. GCN4cc-N-TEV was used as a con-
trol.BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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are cleaved off [5]. Using both types of reporters, we ana-
lyzed the modification dependent interaction of Bad and
14-3-3, as well as the constitutive association of 14-3-3
isoforms.
For 14-3-3 proteins, homo- and heterodimer formation
has been demonstrated [23]. We first performed split-TEV
assays to monitor 14-3-3ε homodimerisation using the
complete set of transcription-coupled and proteolysis-
only reporters with luciferase-based (Fig. 1b) and fluores-
cent readouts (Fig. 1c). Each reporter indicated a specific
interaction of 14-3-3 dimers when compared to control
assays. These control assays contained constructs coding
for the coiled-coil domain from the GCN4 protein (Fig.
1b, c). With respect to the signal-to-noise ratio, the doubly
ERT2-flanked reporter RedERnuc performed best, fol-
lowed by GV-2ER and LucER. We used GV-2ER and LucER
for most experiments, since luciferase assays are less
labour-intensive compared to quantitative fluorescence
analysis. Next, we examined the homo- and heterodimer-
isation of the 14-3-3 isoforms ε and ζ. Here, the N-TEV
fragments were either N- or C-terminally fused to the 14-
3-3 protein isoforms (Fig. 2a). All combinations displayed
a comparable degree of activation and we did not observe
reduced signals that may have been caused by structural
constraints of the differently tagged fusion proteins. Using
split-TEV assays with the GV-2ER reporter, we were able to
measure the constitutive association between 14-3-3ε and
ζ in all possible combinations (Fig. 2b). Corresponding
assays with LucER showed similar results (data not
shown).
Homo- and heterodimerization of 14-3-3 isoforms Figure 2
Homo- and heterodimerization of 14-3-3 isoforms. (a) Schematic representation of a 14-3-3 split-TEV assay. 14-3-3 iso-
forms were fused to N-TEV and C-TEV fragments. Upon homo- or heterodimeric interaction the TEV protease activity is 
reconstituted. (b) Murine 14-3-3 isoforms ε and ζ form homo- and heterodimers. Luciferase readings also verify the flexible 
usage of TEV fragments. GCN4cc domains were used as negative controls. NIH-3T3 cells were transiently transfected with the 
constructs as indicated. RLUs, relative luciferase units, n = 6.BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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Monitoring Akt-1 dependent interactions of Bad and 14-3-
3 in NIH-3T3 fibroblasts and pimary cultured cortical 
neurons
Unphosphorylated Bad promotes apoptosis, however
upon phosphorylation of Ser136 by Akt-1/PKB Bad binds
to 14-3-3 proteins thereby inhibiting its pro-apoptotic
activity [6]. To provide constant Akt-1 activity, we gener-
ated a constitutively active form of murine Akt-1 (myr-
Akt-Δ4-129-HA) [24], which lacks the PH domain, but
contains an N-terminal myristoylation sequence directing
the kinase to the plasma membrane (Fig. 3a). Murine Bad
and a mutant, which cannot be phosphorylated at Ser 136
(Bad-S136A), were fused to the N-terminal TEV fragment.
Murine 14-3-3ε and 14-3-3ζ were both fused to the C-ter-
minal TEV fragment (Fig. 3a). Western blot analysis veri-
fied the proper expression of all fusion constructs at
expected molecular weights (Fig. 3b). Phosphorylation of
Bad by the constitutive form of Akt-1 should facilitate the
interaction of N-TEV-Bad and 14-3-3-C-TEV fusion pro-
teins and subsequent reconstitution of the proteolytic
activity of the complemented TEV protease (Fig. 3c).
Upon co-transfection of constitutively active Akt-1 with
N-TEV-Bad and 14-3-3ε-C-TEV or 14-3-3ζ-C-TEV signal
induction ratios of 22- or 26-fold were detected using the
GV-2ER reporter (Fig. 3d). When applying the cytosolic
proteolysis-only reporter LucER, comparable results were
obtained with slightly reduced induction levels (data not
shown). Replacing Bad by the Bad-S136A mutant abol-
ished the interaction completely, demonstrating that
Ser136 is the crucial residue for the interaction (Fig. 3d)
[7]. Apoptosis promoted by non-phosphorylated Bad
and, conversely, survival signaling exerted by phosphor-
ylated Bad bound to 14-3-3, may be observed [7,13].
When we normalized the readings obtained from the con-
stitutively expressing Renilla luciferase constructs to the
number of cells, an effect of Akt-1 and Bad on the cellular
state became evident. In the presence of constitutive Akt-
1 kinase activity, the Renilla luciferase readings were ele-
vated by approximately 3-fold (Fig. 3e). In contrast, when
Akt-1 was lacking, Renilla  readings were lower, as evi-
denced in the experiment using N-TEV-Bad and 14-3-3ζ-
C-TEV fusions (Fig. 3e). When the phosphorylation defi-
cient Bad-S136A variant was used, Renilla firefly readings
remained unaltered in the presence or absence of Akt-1.
Analogous measurements were obtained using the 14-3-
3ε isoform (Fig. 3e). We could also observe a several-fold
increase in the relative firefly reporter activity if only both
wild-type Bad and constitutively active Akt-1 were present.
To determine the ratio of exogenously added Akt and Bad
versus the endogenous proteins, we performed Western
blots from NIH-3T3 cell lysates singly transfected with Akt
or Bad. DNA amounts used for transfection were propor-
tional to those used in the luciferase assays. Expression
levels of the HA-tagged constitutively active Akt mutant
over endogenous Akt was found to be approximately 1.5
fold (Fig. 4a,b). The levels of the N-TEV-Bad and N-TEV-
Bad-S136A fusion proteins were approximately 3- and
2.5-fold compared to endogenous Bad (Fig. 4c, d). Trans-
fection efficacies of NIH-3T3 cells were found to be 24 ±
2% and 21 ± 3% for EYFP-Bad and EYFP-BadS136A,
respectively, based on FACS analysis (data not shown).
Thus, as judged by the transfection efficiency of single
plasmids, the average level of overexpression in individual
cells will be increased by 5-fold. This calculation, how-
ever, can only serve as an estimation for the split-TEV
assays, since up to five different plasmids are co-trans-
fected, and most likely only a minor fraction of cells will
receive a proportional amount of all plasmids. We moni-
tored the subcellular distribution of the EYFP-Bad and
EYFP-BadS136A fusion constructs by epifluorescent
microscopy with and without co-transfected Akt-1 and
could not detect altereded subcellular localizations (data
not shown).
Applying these split-TEV assays in primary cultured corti-
cal neurons gave similar results for the Akt-1 dependent
interaction of Bad and the 14-3-3ε and ζ isoforms (Fig.
5a). Our results also provide evidence for a function of
these brain-enriched 14-3-3 isoforms with respect to neu-
ronal survival (Fig. 5b).
Monitoring Bad and 14-3-3 interactions by transiently 
activated endogenous Akt-1
Phosphorylation regulates Akt-1 and can be used as a sur-
rogate marker for its activation [25]. We determined the
level of endogenously phosphorylated Akt-1 in stimu-
lated NIH-3T3 fibroblasts by Western blotting using an
antibody directed against the activated, phosphorylated
form of Akt-1. In parallel, we measured the interaction of
Bad and 14-3-3 using split-TEV assays. Akt-1 phosphoryla-
tion was determined in extracts of either starved NIH-3T3
cells (grown in 1% serum) or upon stimulation with 5%
and 10% serum or with purified PDGF-BB (Fig. 6a). As a
measure of the relative level of Akt phosphorylation, we
determined the pixel intensities of the resulting Western
blot bands obtained for endogenous Akt and phosphor-
ylated Akt (Fig. 4b). Peak levels of Akt phosphorylation
were detected 1 h post stimulation and already substan-
tially reduced 6 h following stimulation. Phosphorylation
levels declined to baseline levels within 24 h. (Fig. 6b). In
the corresponding split-TEV assay, the Bad/14-3-3 interac-
tion was used as readout for the activated form of Akt-1.
Stimulations with 5% and 10% serum and the addition of
PDGF substantially increased the readout. Moreover, the
increase was proportional to the relative activation of
endogenous Akt-1 with PDGF-BB being the most potent
stimulus (Fig. 6c). Thus, the split-TEV assay can be used to
measure this phosphorylation-dependent interaction
induced by the transient activity of Akt-1. Moreover, cells
treated with increasing serum concentrations (5% andBMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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Quantifying phosphorylation dependent interactions between Bad and 14-3-3 isoforms Figure 3
Quantifying phosphorylation dependent interactions between Bad and 14-3-3 isoforms. (a) CMV-driven expres-
sion constructs are depicted as bar graphs. Murine Bad, mutated Bad-S136A and murine 14-3-3 isoforms ε and ζ were fused to 
N-terminal or C-terminal TEV fragments as indicated. N-terminal and C-terminal TEV fusions contain a Flag-tag or an HA-tag, 
respectively. The constitutive form of murine Akt-1 (myr-Akt-Δ4-129-HA) lacks the PH domain, but contains an N-terminal 
myristoylation signal and a C-terminal HA-tag. (b) Western blot analysis of expression constructs shown in (a). Calculated pro-
tein sizes are: N-TEV-Bad, 41.0 kDa; N-TEV-Bad-S136A, 41.0 kDa; Const-Akt, 43.4 kDa; 14-3-3ζ-C-TEV, 42.8 kDa; 14-3-3ε-C-
TEV, 44.2 kDa. (c) Principle of TEV fragment fusion proteins used to monitor the phosphorylation dependent interaction of 
Bad and 14-3-3. When Akt-1 kinase activity is present, Bad becomes phosphorylated enabling 14-3-3 to bind and resulting in 
reconstitution of the TEV protease activity. Const-Akt, constitutively active form of murine Akt-1. (d) Luciferase reporter 
assay quantifying the regulated interaction of murine Bad and 14-3-3 isoforms in NIH-3T3 cells. Cells were transfected with the 
indicated constructs. Mock treated cells were transfected with pcDNA3 only. Const-Akt, constitutively active form of murine 
Akt-1. RLUs, relative luciferase units, n = 4. (e) Renilla luciferase readings in NIH-3T3 cells show that only phosphorylated Bad 
influences the cellular state. Measurements were obtained from the same experiment as shown in (d). NIH-3T3 cells were 
transfected with the indicated constructs and the ratio of the mean value of the Renilla luciferase readings over the number of 
seeded cells per well (30000) were plotted.BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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10% FBS, respectively) or stimulated with PDGF-BB dis-
played increased Renilla luciferase activity (Fig. 6d). How-
ever, the increase in Renilla activity was markedly lower
upon PDGF-BB treatment as compared to elevated serum
concentrations (Fig. 6d). Therefore, the split-TEV assays
are unlikely to be compromised by the stimulatory effects
of the PDGF growth factor activity.
Comparison of endogenous versus exogenous Akt and Bad protein levels Figure 4
Comparison of endogenous versus exogenous Akt and Bad protein levels. (a, c) Western blot analyses to determine 
the relative amounts of endogenous protein levels of Akt (55.7 kDa) and Bad (22.1 kDa) versus the corresponding overex-
pressed variants. CMV-driven expression constructs coding for HA-tagged const-Akt (43.4 kDa) and the Flag-tagged N-TEV-
Bad (41.0 kDa) and N-TEV-Bad-S136A (41.0 kDa) proteins were transfected in NIH-3T3 cells cultured in 6-well dishes at DNA 
concentrations adjusted to the amount used for the 96-well-luciferase assays. The upper panel shows that the endogenous Akt 
and Bad proteins as well as the exogenous fusion constructs can be simultaneously detected with α-Akt (a) and α-Bad antibod-
ies (c), respectively. The lower panel probed with α-HA (a) and α-Flag (c) antibodies verifies the additional bands obtained with 
α-Akt (a) and α-Bad (c) as the exogenously introduced const-Akt, N-TEV-Bad and N-TEV-Bad-S136A proteins. (b) Relative 
quantification of the band intensities obtained in (a) reveals that the level of const-Akt protein is approximately 1.5 fold higher 
compared to endogenous Akt. (d) Relative quantification of the band intensities obtained in (c) reveals that the levels of the N-
TEV-Bad and N-TEV-Bad-S136A proteins are between 3 and 2.5 fold higher compared to endogenous Bad.BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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Bad/14-3-3 split-TEV assays in primary cultured neurons Figure 5
Bad/14-3-3 split-TEV assays in primary cultured neurons. (a) Luciferase reporter assay quantifying the regulated inter-
action of murine Bad and 14-3-3 isoforms in murine primary cultured cortical neurons. Cells were transfected with the indi-
cated constructs and LucER as reporter, n = 6. (b) Renilla luciferase readings in primary cultured neurons. Measurements were 
obtained from the same experiment as shown in (a). The values are given as the ratio of the mean value of the Renilla luciferase 
readings and the number of seeded cells per well (60000).BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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Bad/14-3-3 split-TEV assays monitoring the effects of transiently activated endogenous Akt-1 Figure 6
Bad/14-3-3 split-TEV assays monitoring the effects of transiently activated endogenous Akt-1. (a) Western blot 
analyzing the stimulus-dependent activated form of Akt-1. NIH-3T3 cells were treated either in 1%, 5%, 10% or 1% FCS and 
PDGF-BB (P). The phosphorylation of Akt-1 at residue T473 was analyzed after 1 h, 6 h and 24 h after treatment using an α-P-
Akt antibody. Loading was controlled using an α-Akt antibody. (b) Relative quantification of the western blot shown in (a) 
showing the transient activation of endogenous Akt-1 1 h after stimulation of NIH-3T3 cells. (c) Split-TEV assay using Bad-N-
TEV and 14-3-3ζ-C-TEV constructs to measure endogenous activated Akt-1. NIH-3T3 cells were treated as in (a). Analysis was 
performed 6 h after treatment. RLUs, relative luciferase units, n = 4. (d) Renilla luciferase readings in NIH-3T3 cells. Measure-
ments were obtained from the same experiment as shown in (c). NIH-3T3 cells were transfected with Bad-N-TEV and 14-3-
3ζ-C-TEV constructs. The mean value of the Renilla luciferase readings were given as a ratio of the values versus the number 
of seeded cells per well (30000).BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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Bad/14-3-3 split-TEV assays in HEK293 and NIH-3T3 cells using a fluorescent reporter Figure 7
Bad/14-3-3 split-TEV assays in HEK293 and NIH-3T3 cells using a fluorescent reporter. (a-l) FACS analyses of 
HEK293 (a-f) and NIH-3T3 (g-l) cells that were co-transfected with the GV2-ER and G5-EYFPnuc reporter and the indicated 
expression plasmids (Mock indicates empty expression vector pcDNA3). (a-e, g-l) Representative histograms of replicate anal-
yses with the YFP-fluorescence plotted against the PI-fluorescence intensities. Q1 gated cells display increased YFP fluores-
cence, Q2 gated cells are YFP/PI double-positive cells, Q3 are YFP/PI negative cell populations and Q4 represent PI positive 
cells. (f, l) Quantitative analysis of Q1 gated events from all replicates (n = 3) given as number of YFP-positive per 10000 (f, 
HEK293) or 5000 (l, NIH-3T3) cells, respectively.BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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Monitoring regulated Bad and 14-3-3 interactions with a 
fluorescent reporter
Fluorescent activated cell sorting (FACS) was used to
quantify the Akt-1-dependent interaction of N-TEV-Bad
with 14-3-3ζ-C-TEV. Here, the readout was monitored
using a nuclear targeted EYFP reporter in HEK293 (Fig.
7a–f) and NIH-3T3 cells (Fig. 7g–l). In both cell types a 3-
to 4-fold increase in the number of YFP positive cells was
observed, which was dependent on the presence of wild-
type Bad and constitutively active Akt-1 (Fig. 7f,l). The
Akt-1-mediated effect was abrogated when the N-TEV-
BadS136A mutant construct was used (Fig. 7f,l). In paral-
lel, we stained dying cells with the cell-impermeable red
fluorescent nuclear dye propidium iodide (PI). Under all
conditions, the number of PI-positive or PI-YFP double-
positive cells were not substantially altered (Fig. 7a–e and
7g–k, and data not shown) proving that the Akt-1-medi-
ated effects on the cellular state did not bias the split-TEV
assays using the EYFP reporter.
Monitoring adapter interactions with Nrg1-activated 
ErbB4 receptors
Finally, we used the well known phosphorylation-
dependent interactions of cytosolic adapter proteins to
Nrg1-activated ErbB4 [21] to show the applicability of
split-TEV assays to monitor regulated interactions at the
membrane of living cells. Therefore, ErbB4 was fused to
N-TEV and the artificial transactivator Gal4-VP16 (GV)
separated by a TEV protease cleavage site (tevS) (ErbB4-N-
TEV-tevS-GV) (Fig. 8a). Adapter proteins (PI3K subunits α
and β, Grb2 and Shc1) were fused to C-TEV fragments.
For the split-TEV assays, we expressed a Nrg-1 isoform
(Nrg1-typeII-β1a) as a full-length protein [26]. To ensure
that ErbB4 is specifically activated at the cell membrane,
Nrg1-typeII-β1a was separately transfected into PC12 cells
(population 1), whereas ErbB4, the adapters and the GV-
dependent reporter were transfected into a second batch
of PC12 cells (population 2) (Fig. 8b). 20 h post transfec-
tion cell populations 1 and 2 were mixed, and 24 h later
the adapter/ErbB4 receptor interactions were monitored.
The experimental setup of this 2-population assay was
confirmed by co-expressing EYFP in population 1 and
ECFP in population 2. Fluorescence microscopy of YFP
and CFP revealed the existence of two separate cellular
populations with non-overlapping yellow and cyan posi-
tive cells being in close contact (Fig. 8c).
Split-TEV assays show that ErbB4-N-TEV-tevS-GV interacts
with the adapters PI3Kp85α-C-TEV, PI3Kp85β-C-TEV,
Grb2-C-TEV and Shc1-C-TEV only if Nrg1-typeII-β1a was
expressed in neighboring cells (Fig. 8d). The cytosolic pro-
tein FK506-binding protein-C-TEV fusion protein (FKBP-
C-TEV) served as a negative control showing no activation
in the presence or absence of Nrg1-typeII-β1a (Fig. 8d).
The corresponding Renilla luciferase readings are highly
similar between all assays showing that transfection effi-
ciencies were similar, and that secondary stimulatory
effects may have induced the assays (Fig. 8e). Thus, inter-
and intracellular signaling events can be monitored with
appropriately designed split-TEV assays in living cells.
Discussion
Protein modification-dependent PPIs serve complex regu-
latory functions in cellular signaling cascades [27]. How-
ever, the quantitative analysis of these key cellular events
still remains a challenging task. Here, we apply split-TEV
assays to monitor constitutive and transient phosphoryla-
tion-dependent PPIs that occur in the cytosol and at the
membrane of living cells. Thus, split-TEV assays represent
an alternative option towards the goal of analysing regu-
lated PPIs of full-length proteins within signaling cascades
that occur both at the membrane and in the cytosol of liv-
ing cells (this study and [5]).
Using split-TEV, we analyzed the regulated interaction of
Bad with 14-3-3 isoforms in primary cultured neurons.
Cellular assays in most primary cultured cells, including
neurons, still represent a major challenge due to lower
transfection efficiencies and limited availability. With our
transfection protocol, we routinely obtained transfection
efficiencies of primary cultured neurons that did not
exceed 10%. Nonetheless, we were able to robustly meas-
ure the phosphorylation-dependent Bad/14-3-3 interac-
tion in our standard 96-well format. Since observations in
primary cultures may be more relevant to understand cell-
type specific cellular signaling events, split-TEV assays rep-
resent a particularly valuable tool to determine modifica-
tion-regulated interaction profiles in these cells. Although
we mainly focused on luciferase-based reporters in this
study, the fluorescent split-TEV reporter RedERnuc dis-
played a high signal-to-noise ratio and may represent an
additional readout option when cell numbers are limiting
and/or transfection efficiencies are low.
In this report, the association of the pro-apoptotic Bad
and the adapter protein 14-3-3, which only binds to phos-
phorylated Bad, was quantified in heterologous cells and
primary cultured neurons along with the effects on the
cellular state evoked by the interaction itself. Although the
results obtained in NIH-3T3 cells and primary cultured
neurons showed the same tendency, the effect was less
pronounced in primary neurons. This may be caused by
the lower transfection efficiencies and/or expression levels
obtained with primary neurons. In our assays, the trans-
fection efficiencies of NIH-3T3 cells vary between 20–
30%, whereas the relative number of neurons transfected
is generally lower than 10%. The cell type depending dif-
ferences in transfection efficiencies may also explain the
results that we obtained by FACS analyses with HEK293BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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Nrg1 induced interactions of ErbB4 and adapter proteins Figure 8
Nrg1 induced interactions of ErbB4 and adapter proteins. (a) Schematic drawing showing the principle of the assay. 
Upon Nrg stimulation, ErbB4 receptors are activated and Tyr-phosphorylated resulting in binding domains for several adapter 
proteins such as the PI3Kp85 subunits. In the split-TEV assays, ErbB4 is fused to N-TEV, a TEV cleavage site and the transcrip-
tion factor GV (ErbB4-N-TEV-GV). The adapter proteins are fused to C-TEV (such as PI3Kp85-C-TEV). PI3Kp85 binding to 
ErbB4 results in the formation of a functional TEV protease made up of the N-TEV and C-TEV fragments. Proteolytic activity 
releases GV, which can translocate to the nucleus to induce transcription of a luciferase reporter gene. (b) Schematic drawing 
of the experimental setup for the 2-cell-population assay to allow ErbB4 activation exclusively at the cell membrane. The ErbB4 
receptor (dark green rectangle) and the adapters (bright green circle) were transfected into population 1. The ligand neuregu-
lin (Nrg) was transfected into population 2. This verifies that the Nrg induced ErbB4 activation and the subsequent phosphor-
ylation-dependent interaction with the adapter protein are initiated via intercellular signaling at the cell membrane. (c) 
Visualisation of the 2-population assay. EYFP was co-transfected into population 1, ECFP into population 2. EYFP and ECFP 
were allowed to express for 20 h separately. Subsequently, both populations were mixed, and the assay was continued for 
additional 24 h. The merged image shows that YFP and CFP signals are not overlapping and that yellow and cyan signals are fre-
quently in close proximity. Images were taken immediately before the luciferase assay was performed. (d) 2-population luci-
ferase assay depicting the activation of the neuregulin-1 (Nrg1-II-b1a variant) induced phosphorylation-dependent interaction 
between the ErbB4 receptor and the adapter proteins PI3Kp85α, PI3Kp85β, Grb2 and Shc1. Combination of constructs were 
transfected into PC12 cells as indicated. RLUs, relative luciferase units; n = 6. (e) Renilla luciferase readings taken from the 
same assay as depicted in (d). Stimulation with Nrg1-II-b1a does not lead to substantial differences in absolute Renilla luciferase 
readings.BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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and NIH-3T3 cells using the fluorescent EYFPnuc reporter.
Although the results between the cell types and the differ-
ent reporter systems (luciferase versus fluorescence) were
highly similar, the relative robustness of the readout var-
ied. In HEK293, the Akt-1 dependent interaction of 14-3-
3ζ-C-TEV with N-TEV-Bad led to an activation of the
reporter in almost 20% of all cells, whereas the maximum
level of activation in NIH-3T3 was below 2%. However,
the relative induction ratios over controls (interaction of
14-3-3ζ-C-TEV with N-TEV-Bad without Akt-1 or with the
phosphorylation mutant BadS136A variants) were com-
parable between cell lines. This difference could be due to
variable numbers of plasmids taken up by individual
cells, as up to five plasmids are required for the split-TEV
assays used. In NIH-3T3 cells, split-TEV was also success-
fully applied to measure endogenous phosphorylation
levels of Akt-1, proving the high sensitivity of split-TEV
assays.
Also, we monitored phosphorylation-dependent interac-
tions between activated ErbB4 receptor tyrosine kinases
and several cytosolic adapter proteins in PC12 cells. In the
presented 2-cell batch assays, ErbB4 was stimulated by a
full-length Nrg1 variant expressed exclusively in neigh-
bouring cells. The chosen isoform of Nrg-1 (Nrg1-typeII-
β1a) requires proteolytic cleavage by extracellulary pro-
teases to yield a soluble, active form [26]. We conclude
that the split-TEV technique may be particularly suited to
study weak and eventually transient protein interactions
with a simple readout format even if complex membrane
signaling is under investigation. Given the enormous
complexity of mutually dependent inter- and intracellular
signaling processes, the need of scalable assay systems,
such as the split-TEV, is apparent. For example, the NRG1
gene generates at least 31 isoforms, which may have dif-
ferent signaling capabilities and/or different receptor
affinities [19]. Nrg1 isoforms can bind to ErbB3 and
ErbB4 receptors with ErbB4 having four splice variants
itself. ErbB receptors can form homo- and heterodimeric
complexes exerting different signaling properties, making
a differential receptor/adapter association analysis in liv-
ing cells a valuable and highly challenging task. We have
shown that split-TEV assays can be designed to study piv-
otal inter- and intracellular signaling events in living cells
with high sensitivity. Given its flexibility and scalability,
the split-TEV technique may help to unravel the complex-
ity of cellular signaling in the future.
Conclusion
Split-TEV assays may complement existing techniques to
study phosphorylation-dependent and transient PPIs that
were induced by intrinsic kinase activities in living cells.
The interactions can be monitored with full-length
cytosolic proteins in heterologous cell lines as well as in
primary cultured neurons. All assays were performed in
multi-plate formats and could therefore be adapted to
higher throughput to screen for pharmacological sub-
stances interfering with pivotal PPIs within cellular signal-
ing cascades.
Methods
Construction of Expression Plasmids
Expression plasmids were constructed with PCR tech-
niques using proofreading polymerases (Pfu and EasyA,
Stratagene). PCR products were either TA-overhang sub-
cloned in pGEM-T (Promega) using standard molecular
cloning procedures or were modified with attB1/2 recom-
bination sites for the 'Gateway' recombination cloning
(Invitrogen). All protocols were performed according to
the manufacturers instruction (Invitrogen). Reporter plas-
mids used have been described recently [5].
Western Blotting of Expression Constructs
COS1 cells were transfected with 5 μg of plasmid DNA per
sample, cultured for 40 h and lysed in RIPA buffer (50
mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Tri-
ton X-100, 1% sodium deoxycholate, 0.1% SDS), includ-
ing protease inhibitors (Complete kit, Roche). The lysates
were sonicated and the cell debris was removed by centrif-
ugation. Equal amounts of lysate containing LDS sample
buffer were loaded on precasted gels (Invitrogen) and
blotted on PVDF membranes (Amersham Biosciences).
The membranes were blocked in blocking buffer (5%
milkpowder in TBS-T) and probed with primary
(αFlagM2 1:5000 in blocking buffer, Sigma; αHA 1:1000,
Roche) and secondary antibodies (HRP goat-α-mouse
1:5000, HRP goat-α-rabbit 1:5000, HRP goat-α-rat
1:1000, Jackson Immuno Research Labs). Anti-phospho-
Akt (Ser473) (Cell Signaling Technology, #9272, 1:1000),
anti-Akt-1 (Cell Signaling, #9271, 1:1000) and anti-Bad
antibodies (Cell Signaling, #9292, 1:1000) were used to
determine exogenous, activated and total amounts of Akt-
1 and Bad in transfected and stimulated NIH-3T3 cells.
For luminescence detection, the Western Lightning kit
(Perkin Elmer Life Science) was used and ECL-films
(Amersham) were developed in a Kodak X-OMAT 1000.
Band intensities of endogenous and transfected proteins
were determined using ImageJ 1.37. Scanned images were
computationally inverted, the bands in question were
equally boxed, and the intensities were measured and
converted to mean values. For comparison, the band
intensities representing the endogenous protein were set
to 100% and plotted as histogram.
Cultivation and Transfection of Cell Lines
NIH-3T3, COS1 and PC12 cells were cultured in DMEM
with 1 g/l glucose (BioWhittaker) and supplemented with
5% fetal calf serum (FCS, Invitrogen) (NIH-3T3 and
COS1 cells) or 10% FCS and 10% horse serum (HS, Invit-
rogen) (PC12 cells) and 200 mM Glutamax (Invitrogen).BMC Biotechnology 2008, 8:55 http://www.biomedcentral.com/1472-6750/8/55
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For luciferase experiments, NIH-3T3 cells were cultured in
1% FCS and analysed 24 h (using proteolysis-only report-
ers) or 24 to 48 h (using 'transcription-coupled' reporters)
post transfection. In 2-population cell assays, PC12 cells
were cultured with 5% FCS and 5% HS. Therefore, PC12
cells were separated in two populations and transfected
with plasmids encoding for ligands only (population 1)
or membrane and cytosolic proteins along with reporters
(population 2). Populations 1 and 2 were allowed to indi-
vidually express the proteins for 20 h. Subsequently, the
cells were washed, the populations were mixed and the
final assay was performed 24 h later. Cells were trans-
fected with Lipofectamine2000 (Invitrogen) according to
the manufacture's instructions. For specific stimulation of
the PI3K-Akt pathway, NIH-3T3 cells were treated with
PDBF-BB (50 ng/ml, PeproTech).
Preparation and Transfection of Primary Neurons
Primary neurons were prepared from the cortex and hip-
pocampus of E17 old mouse embryos. After preparation
of the hippocampus and the cortex, both tissues were
incubated in HBSS (supplemented with 10 mM Hepes,
NaHCO3  and 1× penicillin/streptomycin) containing
0.5× trypsin-EDTA and 0.1 mg/ml DNAseI for 10 min at
37°C. The cells were further dissociated by gentle tritura-
tion until a homogenous dispersion was achieved. The
cells were pelleted (800 rpm for 10 min) and resuspended
in Neurobasal medium supplemented with B27-supple-
ment (1:50, Gibco), L-glutamine (1:100, 2 mM), penicil-
lin (100 U/ml), streptomycin (100 μg/ml), MK-801 (10
μM, Tocris), NGF (0.1 ng/μl, Promega) and β-FGF (0.1
ng/μl, PeproTech). Finally, cells were counted and plated
for the luciferase assays (96-well plate: 6 × 104/well). For
transient transfections, the primary neurons were cultured
for 3 to 4 days, followed by the removal of 60% of the
medium, and the addition of the Lipofectamine2000/
plasmid mix. Six hours later, 75% of the medium was
removed, and replaced by fresh medium and analysed 24
h post transfection.
Luciferase Measurements
Luciferase assays were performed in 96-well plates using
the Dual-Luciferase kit (Promega). For standardization of
transfection variability and increased readout stability, a
mix of plasmids coding for renilla-luciferase (RL) was
used (CMV-RL, TK-RL and SV40-RL; 1:2:10 molar propor-
tions, respectively). DNA amounts were adjusted to equal
levels with pcDNA3 or pCMV-EYFP. Cells were treated
with lysis reagent (Promega) according to the manufactur-
ers instructions. Coupled firefly and Renilla-luciferase
assays were performed in a Lumat LB96V reader (Berthold
Technologies). Results were given as Renilla-normalized
relative luciferase units (RLUs) ± standard deviation (SD).
All experiments were repeated at least three times with a
minimum of three replicates for each data point.
FACS Analysis
For FACS analysis, HEK293 and NIH-3T3 cells were
seeded on day 1 in 24 well plates with 3 × 105 and 105 cells
per well, respectively. On day 2, cells were transfected with
expression constructs along with the GV2ER plasmid and
a nuclear targeted Gal4-dependent EYFP reporter (G5-
EYFPnuc) using Lipofectamin 2000 (Invitrogen). 30 h
later, cells were stained for 30 min with the nuclear dyes
Hoechst 33342 (Hoe, cell permeable, labels all cells) and
Propidium Iodide (PI, cell impermeable, labels dying
cells) (Invitrogen) according to manufacturer specifica-
tions. Single cell suspensions were prepared by trypsin
treatment and thorough pipetting in PBS containing 5
mM EDTA. Before FACS analysis, cells were filtered
through 50 μm nylon meshes and kept on ice. Hoe, YFP
and PI analyses were performed with standard filter set-
tings, gates were adjusted with negative and positive con-
trol samples. All experiments were performed with three
independent replicates for each data point. Results were
given as numbers of YFP-positive cells per 10000
(HEK293) or 5000 (NIH-3T3) Hoe-positive stained cells.
FACS measurements were performed with a FACS-Aria
(Becton-Dickinson). Errors are given as SEM.
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